232 related articles for article (PubMed ID: 23831951)
1. Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.
Narayanaswami V; Somkuwar SS; Horton DB; Cassis LA; Dwoskin LP
Biochem Pharmacol; 2013 Sep; 86(5):656-65. PubMed ID: 23831951
[TBL] [Abstract][Full Text] [Related]
2. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
[TBL] [Abstract][Full Text] [Related]
3. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
4. PD123319, angiotensin II type II receptor antagonist, inhibits oxidative stress and inflammation in 2, 4-dinitrobenzene sulfonic acid-induced colitis in rat and ameliorates colonic contractility.
Zizzo MG; Caldara G; Bellanca A; Nuzzo D; Di Carlo M; Serio R
Inflammopharmacology; 2020 Feb; 28(1):187-199. PubMed ID: 31321575
[TBL] [Abstract][Full Text] [Related]
5. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
Cao YJ; Surowy CS; Puttfarcken PS
Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
[TBL] [Abstract][Full Text] [Related]
6. AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.
Rodriguez-Campos M; Kadarian C; Rodano V; Bianciotti L; Fernandez B; Vatta M
Cell Mol Neurobiol; 2000 Dec; 20(6):747-62. PubMed ID: 11100981
[TBL] [Abstract][Full Text] [Related]
7. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
[TBL] [Abstract][Full Text] [Related]
8. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
9. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
[TBL] [Abstract][Full Text] [Related]
10. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
Barik J; Wonnacott S
Mol Pharmacol; 2006 Feb; 69(2):618-28. PubMed ID: 16269536
[TBL] [Abstract][Full Text] [Related]
11. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
12. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
[TBL] [Abstract][Full Text] [Related]
13. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.
Brown DC; Steward LJ; Ge J; Barnes NM
Br J Pharmacol; 1996 May; 118(2):414-20. PubMed ID: 8735646
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ mobilization in adult rat cardiomyocytes by angiotensin type 1 and 2 receptors.
Shao Q; Saward L; Zahradka P; Dhalla NS
Biochem Pharmacol; 1998 May; 55(9):1413-8. PubMed ID: 10076533
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin type 2 receptor on secretion of the locus coeruleus in stress-induced hypertension rats.
Gong WK; Lü J; Wang F; Wang B; Wang MY; Huang HP
Brain Res Bull; 2015 Feb; 111():62-8. PubMed ID: 25562714
[TBL] [Abstract][Full Text] [Related]
16. Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter.
de Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Dec; 319(3):1088-95. PubMed ID: 16985169
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT(1)-receptor blockers enhance cardiac responses to parasympathetic nerve stimulation via presynaptic AT(1) receptors in pithed rats.
Yamaki F; Arai T; Aoyama M; Watanabe A; Takata Y
J Pharmacol Sci; 2013; 122(1):28-33. PubMed ID: 23603931
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
Cao YJ; Surowy CS; Puttfarcken PS
J Pharmacol Exp Ther; 2005 Mar; 312(3):1298-304. PubMed ID: 15542623
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
